Search results for "Neoplastic"

showing 10 items of 2901 documents

Perfusion computed tomography of intracranial meningiomas: In vivo correlation of cerebral blood volume and vascular permeability

2015

Background A noninvasive method to predict the grade of a meningioma would be desirable since it would anticipate information about tumour nature, recurrence and improve tumour management and outcomes. The aim of the present study was to assess the ability of perfusion computed tomography (PCT) technique in predicting the meningioma grade before surgery. Data from PCT, such as cerebral blood volume (CBV) and permeability surface (PS), were correlated with immunohistolopathological information. Methods Twenty-three patients with a diagnosis of intracranial meningioma underwent PCT for pre-surgical evaluation of CBV and PS. During surgery, samples from the centre and periphery of the tumour w…

Malemedicine.medical_specialtyRadiology Nuclear Medicine and ImagingneoangiogenesisNeoplastic DiseasePerfusion ImagingVascular permeabilityBlood volumePerfusion scanningCD-34; Meningioma; endoglin; neoangiogenesis; perfusion computed tomography; permeability surface-area product; Aged; Blood Volume; Capillary Permeability; Cerebrovascular Circulation; Cohort Studies; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Grading; Perfusion Imaging; Prospective Studies; Tomography X-Ray ComputedMeningiomaCapillary PermeabilityCohort StudiesmedicineMeningeal NeoplasmsHumansCD-34Prospective StudiesProspective cohort studyMeningeal NeoplasmTomographyAgedendoglinpermeability surface-area productBlood Volumebusiness.industrySettore MED/27 - NeurochirurgiaMedicine (all)General MedicineEndoglinMiddle Agedmedicine.diseaseNeoangiogenesiPeripheralX-Ray ComputedProspective StudieCerebrovascular CirculationCD-34; Endoglin; Meningioma; Neoangiogenesis; Perfusion computed tomography; Permeability surface-area product; Aged; Blood Volume; Capillary Permeability; Cerebrovascular Circulation; Cohort Studies; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Grading; Perfusion Imaging; Prospective Studies; Tomography X-Ray Computed; Neurology (clinical); Radiology Nuclear Medicine and Imaging; Medicine (all)perfusion computed tomographyFemaleRadiologyNeurology (clinical)Cohort StudieNeoplasm GradingbusinessTomography X-Ray ComputedMeningiomaPerfusionHuman
researchProduct

Correlation between the effects of retinoic acid and dexamethasone on liver tyrosine aminotransferase

1997

A single dose of 50 microg of trans-retinoic acid administered to rats significantly raised the level of hepatic tyrosine after a few hours. This effect was compared with that of dexamethasone and a possible correlation between these effectors was also investigated. An equal increase in enzyme activity level caused by retinoic acid was observed in adrenalectomized rats, leading to the suggestion that the effect of retinoic acid on liver tyrosine aminotransferase is independent of glucocorticoids. However, the study of the binding activity of the liver nuclear glucocorticoid receptors vs dexamethasone showed that this activity is favoured by retinoic acid, whereas no variation was evidenced …

Malemedicine.medical_specialtyReceptors Retinoic AcidEndocrinology Diabetes and MetabolismClinical BiochemistryTyrosine TransaminaseRetinoic acidretinoic acid receptorAntineoplastic AgentsTretinoindexamethasoneBiologyBiochemistrychemistry.chemical_compoundReceptors GlucocorticoidEndocrinologyGlucocorticoid receptorTyrosine aminotransferaseInternal medicineglucocorticoid receptorretinoic acidmedicineAnimalsRats WistarTyrosineReceptorMolecular BiologyDexamethasoneTyrosine TransaminaseBinding SitesAdrenalectomyCell BiologyRatsEndocrinologyLiverchemistryTyrosineMolecular Medicinetyrosine aminotransferaseInjections IntraperitonealGlucocorticoidmedicine.drug
researchProduct

Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the ran…

2019

Background: Secondary resection of initially unresectable colorectal cancer liver metastases (CRLM) can prolong survival. The added value of selective internal radiotherapy (SIRT) to downsize lesions for resection is not known. This study evaluated the change in technical resectability of CRLM with the addition of SIRT to FOLFOX-based chemotherapy. Methods: Baseline and follow-up hepatic imaging of patients who received modified FOLFOX (mFOLFOX6: fluorouracil, leucovorin, oxaliplatin) chemotherapy with or without bevacizumab (control arm) versus mFOLFOX6 (with or without bevacizumab) plus SIRT using yttrium-90 resin microspheres (SIRT arm) in the phase III SIRFLOX trial were reviewed by thr…

Malemedicine.medical_specialtyTime FactorsHepatic resectionTreatment outcomeAntineoplastic Agents030230 surgeryMicrosphereClinical study03 medical and health sciences0302 clinical medicinemedicineHepatectomyHumansNeoplasm MetastasisChirurgieLiver imagingRetrospective Studiesbusiness.industryIndividual participant dataLiver NeoplasmsFollow up studiesPatient dataOriginal ArticlesMiddle AgedTreatment Outcome030220 oncology & carcinogenesisFamily medicineHPBLower GISurgeryOriginal ArticleFemaleRadiotherapy AdjuvantbusinessColorectal NeoplasmsTomography X-Ray Computed:Ciencias de la Salud::Oncología [Materias Investigacion]Follow-Up Studies
researchProduct

Essential thrombocythemia terminating in pure erythroleukemia

2004

Transformation into acute leukemia is a rare event in essential thrombocythemia (ET). The blasts are usually of myeloid, rarely of megakaryoblastic differentiation. We present the case of a patient with pure erythroleukemia after a nearly 10-year course of ET, which was treated with hydroxyurea. The patient, a 58-year-old male, presented with an elevated thrombocyte count (926,000/μL) and normal values of hemoglobin and leukocytes. After 10 years of therapy with hydroxyurea, the patient developed acute leukemia of solely erythroid differentiation. Chemotherapy with cytarabine and daunorubicin resulted in incomplete remission. The patient died 2 months after diagnosis of acute erythroleukemi…

Malemedicine.medical_specialtyTime FactorsMyeloidDaunorubicinmedicine.medical_treatmentFatal OutcomeBone Marrowhemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansThrombocytosisChemotherapyAcute leukemiaHematologybusiness.industryEssential thrombocythemiaHematologyMiddle Agedmedicine.diseaseCell Transformation Neoplasticmedicine.anatomical_structureImmunologyCytarabineAcute erythroleukemiaLeukemia Erythroblastic Acutebusinessmedicine.drugAmerican Journal of Hematology
researchProduct

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a m…

2006

ABSTRACT Background: Combinations of gemcitabine–oxaliplatin, gemcitabine–5-fluorouracil (5-FU) and 5-FU–oxaliplatin have synergistic activity and nonoverlapping adverse effect profiles. This trial assessed efficacy and safety of the triple combination gemcitabine–oxaliplatin and infusional 5-FU in patients with locally advanced (n = 11) or metastatic (n = 32) pancreatic adenocarcinoma. Patients and methods: A total of 43 eligible patients were treated with intravenous infusions of gemcitabine (900 mg/m2 over 30 min), followed by oxaliplatin (65 mg/m2 over 2 h) and 5-FU (1500 mg/m2 over 24 h) on days 1 and 8 of a 21-day cycle. Results: Among all 43 patients, the tumor response rate was 19% …

Malemedicine.medical_specialtyTime FactorsOrganoplatinum Compoundsmedicine.medical_treatmentPhases of clinical researchAdenocarcinomaDeoxycytidineGastroenterologyDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLost to follow-upInfusions IntravenousAgedChemotherapyCardiotoxicitybusiness.industryCombination chemotherapyHematologyMiddle AgedGemcitabineChemotherapy regimenGemcitabineSurgeryOxaliplatinOxaliplatinPancreatic NeoplasmsSurvival RateTreatment OutcomeOncologyDisease ProgressionQuality of LifeFemaleFluorouracilbusinessmedicine.drugAnnals of Oncology
researchProduct

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent…

2015

Summary Background Acute myeloid leukaemia mainly affects elderly people, with a median age at diagnosis of around 70 years. Although about 50–60% of patients enter first complete remission upon intensive induction chemotherapy, relapse remains high and overall outcomes are disappointing. Therefore, effective post-remission therapy is urgently needed. Although often no post-remission therapy is given to elderly patients, it might include chemotherapy or allogeneic haemopoietic stem cell transplantation (HSCT) following reduced-intensity conditioning. We aimed to assess the comparative value of allogeneic HSCT with other approaches, including no post-remission therapy, in patients with acute…

Malemedicine.medical_specialtyTransplantation ConditioningGemtuzumab ozogamicinmedicine.medical_treatmentAntibodies Monoclonal HumanizedCOUNCIL AML11 TRIALEUROPEAN LEUKEMIANETInternal medicinehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointINDUCTION CHEMOTHERAPYHumansTransplantation HomologousProspective StudiesADULT PATIENTS610 Medicine & healthBusulfanMETAANALYSISAgedMYELODYSPLASTIC SYNDROMEChemotherapyRISK-ADAPTED APPROACHbusiness.industryRemission InductionHematopoietic Stem Cell TransplantationInduction chemotherapyHematology1ST COMPLETE REMISSIONTotal body irradiationMiddle AgedGemtuzumabGEMTUZUMAB OZOGAMICINSurgeryFludarabineTransplantationSurvival RateLeukemia Myeloid AcuteAminoglycosidesTreatment OutcomeSURVIVALFemaleNeoplasm Recurrence LocalbusinessBusulfanVidarabinemedicine.drugLancet. Haematology
researchProduct

Extent of Surgery in Rhabdomyosarcoma of Urogenital Structures

1989

After high inguinal semicastration in group-1 paratesticular rhabdomyosarcoma (RMS), the patient having undergone chemotherapy can be followed closely by CT scanning without retroperitoneal lymphadenectomy. In contrast, retroperitoneal RMS should be operated on as radically as possible after downstaging the tumor mass. In RMS of the female genitalia locally limited organ-preserving surgery is the method of choice. The prognosis is excellent with adjuvant chemotherapy. Only 20% of all bladder RMS arise from the bladder dome or the movable part of the bladder, where primary partial resection including a safety margin of 3 cm of healthy tissue is possible. The majority, however, arising from t…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentProstatic urethraAntineoplastic Combined Chemotherapy ProtocolsRhabdomyosarcomamedicineHumansChildRhabdomyosarcomaUpper urinary tractGenitourinary systembusiness.industryUrinary diversionRadiotherapy DosagePrognosismedicine.diseaseCombined Modality TherapySurgeryNeck of urinary bladdermedicine.anatomical_structureFemalebusinessContinent Urinary DiversionUrogenital NeoplasmsChemoradiotherapyFollow-Up StudiesEuropean Urology
researchProduct

Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant …

2011

Objective To investigate the activity and toxicity of metronomic chemotherapy with low-dose oral cyclophosphamide (CTX) and methotrexate (MTX) in patients with metastatic CRPC that progresses after docetaxel. Patients with castration-resistant prostate cancer (CRPC) that progresses after docetaxel may benefit from receiving further chemotherapy. Methods Patients were treated with CTX 50 mg/d p.o. plus MTX 2.4 mg p.o. twice per week without rest periods. All patients received simultaneous luteinizing hormone-releasing hormone analogue. Prostate-specific antigen (PSA) response was defined as a 50% reduction on 2 evaluations at least 4 weeks apart. Objective response was measured according to …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentSalvage therapyPhases of clinical researchAdministration OralAntineoplastic AgentsDocetaxelAdenocarcinomaGastroenterologyCyclophosphamide docetaxel methotrexate metronomic chemotherapy prostate carcinomaSettore MED/24 - UrologiaProstate cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansTreatment FailureCyclophosphamideSalvage TherapyChemotherapyLeukopeniabusiness.industryProstatic Neoplasmsmedicine.diseaseMetronomic ChemotherapySurgeryMethotrexateDocetaxelTolerabilityAdministration MetronomicTaxoidsmedicine.symptombusinessmedicine.drug
researchProduct

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.

2005

OBJECTIVES To report the long-term follow-up of patients with locally advanced bladder cancer treated with either adjuvant combined chemotherapy with methotrexate, vinblastine, doxorubicin/epirubicin, and cisplatin (MVAC/MVEC) or no additional treatment after radical cystectomy, to examine various survival endpoints and factors associated with long-term survival. PATIENTS AND METHODS Between May 1987 and December 1990, 49 patients undergoing radical cystectomy for locally advanced bladder cancer were randomized to observation only or adjuvant systemic chemotherapy with three cycles of MVAC/MVEC (methotrexate 30 mg/m2 on day 1, 15 and 22; vinblastine 3 mg/m2 on day 2, 15 and 22; doxorubicin …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastineDisease-Free SurvivalCystectomyAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansAgedEpirubicinChemotherapyBladder cancerbusiness.industryHazard ratioCombination chemotherapyMiddle Agedmedicine.diseaseInterim analysisCombined Modality TherapyVinblastineSurgeryMethotrexateTreatment OutcomeUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinLymphatic MetastasisFemaleCisplatinNeoplasm Recurrence Localbusinessmedicine.drugEpirubicinFollow-Up StudiesBJU international
researchProduct

Surgery in rhabdomyosarcoma of the bladder, prostate and vagina

1995

The treatment of bladder and prostate rhabdomyosarcoma (RMS) is highly controversial. Aside from chemotherapy, treatment modalities include conservative surgery, radical surgery, and pre-, intra-, or postoperative irradiation. Between 1968 and 1993, 78 children with RMS were treated at our institution. In all, 22 tumors were located in the urogenital tract (bladder/prostate, 13; paratesticular, 5; vaginal, 2; others, 2). Altogether, 6 patients had stage II disease; 7, stage III disease; and 2, stage IV disease. All 15 patients with RMS of the bladder, prostate, or vagina received chemotherapy, and 4 had additional radiotherapy. Surgery was also done in 10 patients; parents refused an operat…

Malemedicine.medical_specialtyVaginal NeoplasmsAdolescentUrologymedicine.medical_treatmentProstate RhabdomyosarcomaVaginal diseaseProstateAntineoplastic Combined Chemotherapy ProtocolsRhabdomyosarcomamedicineHumansRadical surgeryStage (cooking)ChildRhabdomyosarcomaRetrospective StudiesUrinary bladderbusiness.industryInfantProstatic Neoplasmsmedicine.diseaseSurgeryRadiation therapyTreatment Outcomemedicine.anatomical_structureUrinary Bladder NeoplasmsChild PreschoolFemalebusinessFollow-Up StudiesWorld Journal of Urology
researchProduct